26 September 2025
Annual Report Waiver and Delisting Timetable
Vital Limited (NZX: VTL) announces that NZ RegCo has granted it a waiver from NZX Listing Rule 3.6.1, which means that Vital is not required under that Rule to release to the market and send to shareholders an annual report related to Vital’s financial year ended 30 June 2025. Vital previously released to the market its audited financial statements for that financial year, on 29 August 2025.
The waiver is conditional on Vital releasing this announcement. The reasons for the waiver are set out in the NZ RegCo waiver decision released to the market today, including that Tait International Limited has now commenced the Takeovers Code compulsory acquisition process to acquire the remaining shares in Vital for $0.45 per share.
Given the compulsory acquisition process has begun, NZ RegCo has advised Vital that it will suspend trading in Vital shares and, at Vital’s request, will then cancel the quotation of those shares and delist Vital. There will be no further trading in Vital shares through NZX after trading is suspended, and any on-market trades before the suspension takes effect will be settled on the usual T+2 basis.
The timetable for compulsory acquisition and delisting is as follows:
Tait commenced compulsory acquisition of the outstanding shares in Vital - 26 September 2025
Trading in Vital shares is suspended - Close of trading, 3 October 2025
Cessation of quotation of Vital shares and delisting of Vital - Close of trading, 7 October 2025.
Last date for outstanding Vital shareholders to voluntarily transfer shares to Tait under the compulsory acquisition process - 17 October 2025
Last date for Tait to effect the compulsory acquisition of any Vital shares for which it did not receive a voluntary share transfer - 24 October 2025
ENDS
For investor relations enquiries, please contact John McMahon, Vital Chairman on [email protected] or 021 0914 0236
For media enquiries, please contact Richard Llewellyn on [email protected] or 027 5232362
The S&P/NZX 50 Index was 42.06 points or 0.32% lower at 13,111.73.
Levies on drugs will be imposed on companies that aren’t building plants in the US.
At the AGM, a shareholder cited Turners' “very aggressive marketing strategy”.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details